Extra-articular rheumatoid arthritis: Prevalence and mortality

Rheumatology

Volumn 38, Issue 7, 1999, Pages 668-674

  Turesson, C ^a,b   Jacobsson, L ^a   Bergstrom U ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cardiovascular co morbidity; Extra articular manifestations; Mortality; Pericarditis; Pleuritis; Prevalence; Rheumatoid arthritis; Vasculitis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CAUSE OF DEATH; FEMALE; HEART DISEASE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERICARDITIS; PLEURISY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SURVIVAL RATE; SWEDEN; VASCULITIS;

ADOLESCENT; ADULT; AGED; ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COHORT STUDIES; COMORBIDITY; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; SEROSITIS; SWEDEN; VASCULITIS;

EID: 0032753735     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/38.7.668     Document Type: Article

References (47)

1. Hochberg M. Adult and juvenile rheumatoid arthritis: current epidemiologic concepts. Epidemiol Rev 1981; 3:27-44.
2. Roubenoff R, Roubenoff RA, Cannon JG, Kehayias JJ, Zhuang H, Dawson-Hughes B et al. Rheumatoid cachexia: cytokine driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest 1994;93:2379-86.
3. Townheed TE, Brouillard DE, Yendt E, Anastassiades TA. Osteoporosis in rheumatoid arthritis: Findings in the metacarpal, spine, and hip and a study of the determinants of both localized and generalized osteopenia. J Rheumatol 1995;22:440-3.
4. Motulsky OG, Weinberg S, Saphir O, Rosenberg E. Lymph nodes in rheumatoid arthritis. Arch Intern Med 1952;90:660-76.
5. Wilkinson M, Kirk J. Leg ulcers complicating rheumatoid arthritis. Scot Med J 1965;10:175-82.
6. Nishikawa JA. Are leg ulcers in rheumatoid arthritis due to vasculitis? Eur J Rheum Inflam 1983;6:288-90.
7. Gordon DA, Stein JL, Broder I. The extraarticular manifestations of rheumatoid arthritis. A systemic analysis of 127 cases. Am J Med 1973;54:445-52.
8. Geirsson A, Sturfelt G, Truedsson L. Clinical and serological features of severe vasculitis in rheumatoid arthritis: prognostic implications. Ann Rheum Dis 1987;46:727-33.
9. Cobb S, Andersen F, Bauer W. Length of life and cause of death in rheumatoid arthritis. N Engl J Med 1953;249:553-6.
10. Monson RR, Hall AP. Mortality among arthritics. J Chron Dis 1976;29:459-67.
11. Koota K, Isomaki H, Mutru O. Death rate and cause of death in RA patients during a period of five years. Scand J Rheumatol 1977;6:241-4.
12. Jacobsson LTH, Knowler WC, Pillemer S, Hanson RL, Pettitt DJ, Nelson RG et al. Rheumatoid arthritis and mortality. A longitudinal study in Pima Indians. Arthritis Rheum 1993;36:1045-53.
13. Symmons DPM, Prior P, Scott DL, Brown R, Hawkins CF. Factors influencing mortality in rheumatoid arthritis. J Chron Dis 1986;39:137-45.
14. Heliövaara M, Aho K, Aromaa A, Maatela J, Reuanen A. Rheumatoid factor, chronic arthritis and mortality. Ann Rheum Dis 1995;54:811-4.
15. Mitchell DM, Spitz PW, Young DY, Bloch DA, McShane DA, Fries JF. Survival, prognosis and causes of death in rheumatoid arthritis. Arthritis Rheum 1986;29:706-14.
16. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA et al. The mortality of rheumatoid arthritis. Arthritis Rheum 1994;37:481-94.
17. Allebeck P, Ahlbom A, Allander E. Increased mortality among persons with rheumatoid arthritis, but where RA does not appear on death certificate. Scand J Rheumatol 1981;10:301-6.
18. Vandenbroucke JP, Hazevoet HM, Cats A. Survival and cause of death in rheumatoid arthritis: a 25-year prospective follow-up. J Rheumatol 1984;11:158-61.
19. Prior P, Symmons DPM, Scott DL, Brown R, Hawkins CF. Cause of death in rheumatoid arthritis. Br J Rheumatol 1984;23:92-9.
20. Wållberg-Jonsson S, Öhman M-L, Rantapää-Dahlqvist S. Cardiovascular morbidity and mortality in patients with rheumatoid arthritis in northern Sweden. J Rheumatol 1997;24:445-51.
21. Allebeck P, Rodvall Y, Allander E. Mortality in rheumatoid arthritis, particularly as regards drug use. Scand J Rheumatol 1985;14:102-8.
22. Myllykangas-Luossojävi R, Aho K, Kautiainen H, Isomäki H. Shortening of life span and causes of excess mortality in a population based series of excess mortality in a population based series of subjects with rheumatoid arthritis. Clin Exp Rheumatol 1995;13:149-53.
23. Myllykangas-Lousojärvi R, Aho K, Kautiainen H, Isomäki H. Cardiovascular mortality in women with rheumatoid arthritis. J Rheumatol 1995;22:1065-7.
24. Erhardt CC, Mumford PA, Venables PJW, Maini RN. Factors predicting the prognosis in rheumatoid arthritis: an eight year prospective study. Ann Rheum Dis 1989;48:7-13.
25. Hara KS, Ballard DJ, Ilstrup DM, Connolly DC, Vollersten RS. Rheumatoid pericarditis: clinical features and survival. Medicine 1990;69:81-91.
26. Foster AC, Forstot SL, Wilson LA. Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Ophthalmology 1984;91:1253-63.
27. Scott DGI, Bacon PA, Tribe CR. Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine (Baltimore) 1981;60:288-97.
28. Voskuyl AE, Zwinderman AH, Westedt ML, Vanderbroucke JP, Breedveld FC, Hazes MW. The mortality of rheumatoid vasculitis compared with rheumatoid arthritis. Arthritis Rheum 1996;39:266-71.
29. Vollersten RS, Conn DL, Ballard DJ, Ilstrup DM, Kazmar RE, Silverfiele JC. Rheumatoid vasculitis: survival and associated risk factors. Medicine 1986;65:365-75.
30. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
31. Oleinick A, Mantel N. Family studies in systemic lupus erythematosus: mortality among siblings and offspring of index cases with statistical appendix concerning life table analysis. J Chron Dis 1970;22:617-25.
32. Rothman KJ, Boice JD. Follow up (cohort) studies. Epidemiological analysis with a programmable calculator. NIH publication no. 79-1649. Washington, DC: National Institute of Health, 1979.
33. Kvien TH, Glennås A, Knudsrod OG, Smedstad LM, Mowinckel P, Forre O. The prevalence and severity of rheumatoid arthritis in Oslo. Scand J Rheumatol 1997;26:412-8.
34. Reilly PA, Cosh JA, Maddison PJ, Rasker JJ, Silman AJ. Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients. Ann Rheum Dis 1990;49:363-9.
35. Book C, Jacobsson LTH, Saxne T, Sjöblom KG. Rheumatoid arthritis and mortality: Assessment of risk factors and mortality risk. Arthritis Rheum 1996;39:S242.
36. Pincus T, Brooks RF, Callahan LF. Prediction of long-term mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count measures. Ann Intern Med 1994;120:26-34.
37. Bonfiglio T, Atwater C. Heart disease in patients with seropositive rheumatoid arthritis. Arch Intern Med 1969;124:714-9.
38. Saag KG, Kolluri S, Koehnke RK, Georgou TA, Rachow JW, Hunninghake GW et al. Rheumatoid arthritis lung disease. Arthritis Rheum 1996;39:1711-9.
39. Hakala M. Poor prognosis in patients with rheumatoid arthritis hospitalized for interstitial lung fibrosis. Chest 1988;93:114-8.
40. Anaya J-M, Diethelm L, Ortiz LA, Gutierrez M, Citera G, Welsh RA et al. Pulmonary involvement in rheumatoid arthritis. Semin Arthritis Rheum 1995;24:242-54.
41. Jurik AG, Graudal H. Pleurisy in rheumatoid arthritis. Scand J Rheumatol 1983;12:75-80.
42. Jurik AG, Graudal H. Pericarditis in rheumatoid arthritis. A clinical and radiological study. Rheumatol Int 1986; 6:37-42.
43. Watts RA, Carruthers DM, Symmons DPM, Scott GI. The incidence of rheumatoid vasculitis in the Norwich health authority. Br J Rheumatol 1994;33:832-3.
44. Munro JM, Cotran RS. The pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab Invest 1988; 58:249-61.
45. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimai rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994;89:36-44.
46. Kuller LH, Tracy RP, Shaten J, Meliahn EN. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case control study. Am J Epidemiol 1996;144:537-47.
47. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.